EnlivenHealth Celebrates American Pharmacists Month » Learn More

EnlivenHealth Weekly Recap | May 10th, 2025

Here are the top stories from the last week:

Industry Updates

National Coalition, NACDS Urge Congress to Pass ECAPS Act
The Future of Pharmacy Care Coalition and the National Association of Chain Drug Stores are urging Congress to pass the Ensuring Community Access to Pharmacist Services Act, which aims to ensure Medicare beneficiaries have access to essential care and services provided by pharmacists within state scope of practice laws. Read article »

Pharma AI Council Launches
The council aims to ensure AI solutions address real-world challenges and improve patient outcomes. It includes leaders from pharma, biotech, and med device companies, focusing on compliance and practical industry needs. Read article »

AI at the Counter: How Artificial Intelligence Is Shaping the Future of Pharmacy Practice
AI transforms pharmacy practice by streamlining workflows and enhancing patient care, while pharmacists adapt to new roles and challenges in health care. Read article »

Expert: Understanding OTC Allergy Medications and Symptom Management
Jennifer Guthrie, RPh, district leader at CVS pharmacy describes the different medications to treat allergy symptoms and highlight how CVS stands out when addressing patients’ needs. Read article »

Serve You Rx, Amazon Pharmacy Team Up on Home Delivery Program
Serve You Rx members will have access to online transactions, transparent pricing, automatic refill options, 24/7 access to clinical pharmacists, customer care support, and free same-day home delivery of prescriptions in some regions. Read article »

Bayer U.S. Studies Shed Further Light on Menopause Care
Bayer commissioned two surveys conducted by The Harris Poll to explore the menopause experience for women and providers. These surveys identified gaps in the understanding of the menopause experience for both women and providers. Read article »

NPC Issues New White Paper on 340B Drug Pricing Program
Increases in 340B hospital purchases are associated with $137 in additional annual employer-sponsored premium costs for single coverage and $415 for family coverage. Read article »

NCPA: Any Pharma Tariffs Should Be Tailored to Avoid Increasing Shortages and Costs
NCPA is urging the Trump administration to establish certain exclusions from any tariffs, incentivize U.S. manufacturing through supportive domestic and trade policies, and reform the PBM payment model to strengthen domestic supply chains and reimburse pharmacies fairly. Read article »

Michigan Sues PBMs, Alleging Unlawful Collusion Created ‘Pharmacy Deserts’
Michigan Attorney General Dana Nessel has filed a lawsuit against Express Scripts and Prime Therapeutics, accusing them of colluding to suppress reimbursement rates to independent pharmacies, creating “pharmacy deserts” in Detroit and other areas. Read article »

NACDS Praises Governor Youngkin, Virginia Lawmakers for Transformative Move to ‘Single PBM’
The passage and ultimate signing of this legislation is a pivotal step in the fight to bring accountability and clarity to the practices of pharmacy benefit managers (PBMs). Read article »

Drug, Technology & Treatment Updates

Obicetrapib Plus Ezetimibe Reduced LDL-C in Patients with or At Risk of ASCVD
The fixed-dose combination yielded a 49% greater reduction in low density lipoprotein cholesterol (LDL-C) compared with placebo in Atherosclerotic Cardiovascular Disease patients. Read article »

Vitamin B Supplements Could Aid Glaucoma, Slowing Disease Progression
New research reveals that B vitamins and choline may slow glaucoma progression, offering hope for innovative treatments beyond traditional methods. Read article »

Low-Dose Chlorthalidone Granted FDA Approval for Treatment of Adults with Hypertension
The 12.5-mg dose tablet enhances hypertension treatment options and reduces adverse effects for patients. Read article »

PillSafe Technology Innovations Protects Children from Prescription Medication Risks
A high-tech smart prescription bottle with a WiFi system provides a way to protect children and adolescents from prescription misuse, diversion, accidental overdoses, and medication-related errors. Read article »

Camber Launches Eslicarbazepine Acetate Tablets
Eslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older. Read article »

X

Amplicare is now part of EnlivenHealth®

X

FDSRX is now part of EnlivenHealth®